Finding biomarkers in lung disease and lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have COPD, IPF, or an early-stage lung cancer (stage I–III) that can be removed by surgery.
- You are able to follow study procedures and attend check-ups.
- You do not have an active lung infection or severe flare-up of COPD or IPF.
- You have no other active cancer (except non-melanoma skin cancer) and have not recently taken strong immune-suppressing medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how certain white blood cells behave in people with lung cancer or COPD. It aims to better understand the immune response, which could help develop new treatments.
This trial looks at lung tissue from people with COPD to understand how the disease affects individual cells. It may help develop better treatments in the future.
This study collects airway samples (usually during a bronchoscopy), plus blood and/or urine, to help researchers study lung conditions. It may help advance understanding of lung disease and related biology, but it is not a treatment trial.
This study looks at how certain blood cells react in people with lung conditions like asthma, COPD, pneumonia, or COVID-19. By analyzing a blood sample, researchers hope to learn more about the immune system's role in these diseases, which could lead to better treatments.
This trial looks at “cough capture” samples to better understand what is happening in the lungs. You might be eligible if you’re having a bronchoscopy for medical reasons and don’t already have lung cancer.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.